Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 2/20 | 0.73 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.73 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.73 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.73 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.73 |
| ▸ | HTR6 | P50406 | 5/20 | 0.62 |
| ▸ | F2 | P00734 | 2/20 | 0.61 |
| ▸ | TMPRSS4 | Q9NRS4 | 2/20 | 0.61 |
| ▸ | TP53 | P04637 | 1/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.61 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.61 |
| ▸ | FAAH | O00519 | 1/20 | 0.52 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.52 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.52 |
| ▸ | ELANE | P08246 | 1/20 | 0.52 |
| ▸ | PRTN3 | P24158 | 1/20 | 0.52 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.52 |
| ▸ | MAOA | P21397 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenethylamine SCHEMBL25972 | 0.98 | HTR2A (0.70) | HTR2ACYP2A6SMN1; SMN2TAAR1LOXL2 | |
| Phenethylamine SCHEMBL3721983 | 0.91 | HTR2A (0.67) | HTR2ACYP2A6SMN1; SMN2TAAR1LOXL2 | |
| Phenethylamine SCHEMBL11319344 | 0.86 | HTR2A (0.73) | HTR2ACYP2A6SMN1; SMN2TAAR1LOXL2 | |
| Phenethylamine SCHEMBL27616397 | 0.86 | HTR2A (0.73) | HTR2ACYP2A6SMN1; SMN2TAAR1LOXL2 | |
| Phenethylamine SCHEMBL968 | 0.85 | — | — | |
| Phenethylamine SCHEMBL1799333 | 0.85 | HTR2A (1.00) | HTR2ACYP2A6SMN1; SMN2TAAR1LOXL2 | |
| Phenethylamine SCHEMBL27634208 | 0.85 | HTR2A (1.00) | HTR2ACYP2A6SMN1; SMN2TAAR1LOXL2 | |
| Phenethylamine SCHEMBL1332244 | 0.85 | — | — | |
| Phenethylamine SCHEMBL1331271 | 0.85 | — | — | |
| Phenethylamine SCHEMBL1330939 | 0.85 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 286 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101304780-B | Apparatus containing active substance from tissue | 史密夫及内修公开有限公司 | 2016-12-07 | — | — | CN | claimed |
| EP-1933926-B1 | APPARATUS WITH ACTIVES FROM TISSUE | SMITH & NEPHEW (GB) | 2012-10-24 | — | — | EP | claimed |
| US-8257327-B2 | Wound cleansing apparatus with actives | SMITH & NEPHEW PLC (GB) | 2012-09-04 | — | — | US | claimed |
| EP-2251059-A1 | Apparatus with actives from tissue | Smith & Nephew, PLC (GB) | 2010-11-17 | — | — | EP | claimed |
| US-20100249733-A9 | APPARATUS WITH ACTIVES FROM TISSUE | SMITH & NEPHEW PLC (GB) | 2010-09-30 | — | — | US | claimed |
| EP-1562668-B1 | Medical apparatus for irrigating wounds | SMITH & NEPHEW (GB) | 2009-12-02 | — | — | EP | claimed |
| US-20090143753-A1 | APPARATUS WITH ACTIVES FROM TISSUE | SMITH & NEPHEW PLC (GB) | 2009-06-04 | — | — | US | claimed |
| US-7524315-B2 | Apparatus for aspirating, irrigating and cleansing wounds | SMITH & NEPHEW PLC (GB) | 2009-04-28 | — | — | US | claimed |
| EP-1933926-A1 | APPARATUS WITH ACTIVES FROM TISSUE | Smith & Nephew, PLC (GB) | 2008-06-25 | — | — | EP | claimed |
| WO-2007031765-A1 | APPARATUS WITH ACTIVES FROM TISSUE | SMITH & NEPHEW, PLC (GB) | 2007-03-22 | — | — | WO | claimed |
| US-20060155260-A1 | Apparatus for aspirating, irrigating and cleansing wounds | SMITH & NEPHEW PLC (GB) | 2006-07-13 | — | — | US | claimed |
| EP-1562668-A1 | APPARATUS FOR ASPIRATING, IRRIGATING AND CLEANSING WOUNDS | Smith & Nephew PLC (GB) | 2005-08-17 | — | — | EP | claimed |
| US-20050164945-A1 | Endotheliase-1 ligands | DENDREON CORPORATION | 2005-07-28 | — | — | US | claimed |
| WO-2005041631-A2 | ENDOTHELIASE-1 LIGANDS | DYAX CORP. (US) | 2005-05-12 | — | — | WO | claimed |
| WO-2004037334-A1 | APPARATUS FOR ASPIRATING, IRRIGATING AND CLEANSING WOUNDS | SMITH & NEPHEW PLC (GB) | 2004-05-06 | — | — | WO | claimed |
| US-20260008805-A1 | ADENOSINE ANALOGS FOR THE TREATMENT OF DISEASE | BIOINTERVENE INC (US) | 2026-01-08 | — | — | US | disclosed |
| US-12378543-B2 | Compositions for hemolysis and coagulation regulation and stabilization of extracellular vesicles | STRECK LLC (US) | 2025-08-05 | — | — | US | disclosed |
| WO-2000069908-A1 | INTERACTION BETWEEN THE VHL TUMOUR SUPPRESSOR AND HYPOXIA INDUCIBLE FACTOR, AND ASSAY METHODS RELATING THERETO | ISIS INNOVATION LIMITED (GB) | 2000-11-23 | — | — | WO | disclosed |
| WO-2000062068-A1 | METHOD TO TYPE PRION PROTEINS | D-GEN LIMITED (GB) | 2000-10-19 | — | — | WO | disclosed |
| WO-1999049887-A1 | USE OF PROTEASE INHIBITORS FOR TREATING SKIN WOUNDS | BIOTECH AUSTRALIA PTY. LIMITED (AU) | 1999-10-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260008805-A1 | ADENOSINE ANALOGS FOR THE TREATMENT OF DISEASE | ADORA2B, ADORA2A, ADORA1 | HTR2A 168/4885CYP2A6 463/4885SMN1; SMN2 509/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.